10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,296,000 | -57.6% | 501,952 | -32.6% | 0.02% | -55.3% |
| Q2 2022 | $33,678,000 | -35.2% | 744,274 | +9.0% | 0.05% | -21.7% |
| Q1 2022 | $51,946,000 | -51.3% | 682,863 | -4.6% | 0.06% | -53.8% |
| Q4 2021 | $106,593,000 | -0.1% | 715,581 | -2.4% | 0.13% | -12.2% |
| Q3 2021 | $106,748,000 | -24.8% | 733,247 | +1.2% | 0.15% | -22.9% |
| Q2 2021 | $141,905,000 | +59.3% | 724,669 | +47.2% | 0.19% | +45.5% |
| Q1 2021 | $89,084,000 | +16.2% | 492,181 | -9.1% | 0.13% | +116.4% |
| Q4 2020 | $76,686,000 | +109.5% | 541,570 | +84.4% | 0.06% | -9.0% |
| Q3 2020 | $36,608,000 | +54.0% | 293,615 | +10.3% | 0.07% | +39.6% |
| Q2 2020 | $23,774,000 | +52.5% | 266,203 | +6.4% | 0.05% | +26.3% |
| Q1 2020 | $15,588,000 | +132.9% | 250,081 | +184.9% | 0.04% | +192.3% |
| Q4 2019 | $6,694,000 | +384.0% | 87,773 | +219.9% | 0.01% | +333.3% |
| Q3 2019 | $1,383,000 | – | 27,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |